Document Detail


Challenges and solutions in developing new medications for Schizophrenia.
MedLine Citation:
PMID:  21062617     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Of the 24 million people with schizophrenia worldwide, fewer than 50% receive appropriate care.¹ Even patients with access to the best available treatments suffer from significant functional and social deficits.² This article is based on a teleconference that discussed issues related to the development of new treatments for schizophrenia.
Authors:
-
Related Documents :
16169527 - Neurological abnormalities in schizophrenic twins.
20201847 - Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, a...
21792307 - Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for pati...
9046987 - The effect of antipsychotic medication on relative cerebral blood perfusion in schizoph...
2660277 - Ideology in medical science: class in the clinic.
11010727 - Federal old-age, survivors and disability insurance and supplemental security income fo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical psychiatry     Volume:  71     ISSN:  1555-2101     ISO Abbreviation:  J Clin Psychiatry     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-10     Completed Date:  2011-02-16     Revised Date:  2011-03-05    
Medline Journal Info:
Nlm Unique ID:  7801243     Medline TA:  J Clin Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1391-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / therapeutic use*
Drug Delivery Systems / methods*
Drug Discovery / methods*
Drugs, Investigational / therapeutic use*
Humans
Schizophrenia / drug therapy*
Telecommunications
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Drugs, Investigational

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of clinical markers to identify metabolic syndrome in antipsychotic-treated patients.
Next Document:  The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: functional ...